Markets

USD/NGN₦1,364▼ 0.02%GBP/USD1.3476▲ 0.13%EUR/USD1.1552▲ 0.19%BTC$64,967▲ 1.42%ETH$1,916▲ 2.56%SOL$74.8▲ 1.47%S&P 5007,757.64▲ 3.58%NASDAQ26,690.62▲ 5.19%DOW54,036.93▲ 2.96%FTSE10,901.09▲ 0.30%BRENT$83.55▼ 0.26%GOLD$4,399.7▲ 9.07%

Recent Signals

13 Die, 12 Children Remain in Kwara Terrorists' Den◆Trump Signs New Orders Targeting Birth Tourism and Birthright Citizenship◆Houthis Kill at Least 10 in Yemen Oil Province◆Ebola Cases Surpass 4000 in Democratic Republic of Congo◆UN Renews Palantir Contract Despite Privacy Concerns◆Residents Near Kano Shooting Range Warned of Live Ammunition Exercise◆Trump Administration Wins Right to End TPS Protections for South Sudanese◆UK Defence Secretary Promises Action on Army College Abuse Claims◆Monsters of God Review◆Kenya Police Impersonation Crackdown Ordered◆Meta Faces Record $942 Million Penalty◆Stop Saying "Don't Judge a Book by Its Cover"◆Tory Plan to Ban Foreign Nationals From Social Housing Sparks Criticism◆India Floods Displace Thousands◆Le Court Wins Stage Six of Tour De France Femmes◆Kemi Badenoch Criticizes Early Release Scheme◆Swansea Sign Scotland Striker Stewart◆Trump Safe After Marine One Incident◆Ex-Brazil Forward Pato's Consortium to Buy Northampton◆How China Is Exporting Censorship and Reshaping Global Knowledge◆13 Die, 12 Children Remain in Kwara Terrorists' Den◆Trump Signs New Orders Targeting Birth Tourism and Birthright Citizenship◆Houthis Kill at Least 10 in Yemen Oil Province◆Ebola Cases Surpass 4000 in Democratic Republic of Congo◆UN Renews Palantir Contract Despite Privacy Concerns◆Residents Near Kano Shooting Range Warned of Live Ammunition Exercise◆Trump Administration Wins Right to End TPS Protections for South Sudanese◆UK Defence Secretary Promises Action on Army College Abuse Claims◆Monsters of God Review◆Kenya Police Impersonation Crackdown Ordered◆Meta Faces Record $942 Million Penalty◆Stop Saying "Don't Judge a Book by Its Cover"◆Tory Plan to Ban Foreign Nationals From Social Housing Sparks Criticism◆India Floods Displace Thousands◆Le Court Wins Stage Six of Tour De France Femmes◆Kemi Badenoch Criticizes Early Release Scheme◆Swansea Sign Scotland Striker Stewart◆Trump Safe After Marine One Incident◆Ex-Brazil Forward Pato's Consortium to Buy Northampton◆How China Is Exporting Censorship and Reshaping Global Knowledge◆

Cardiovascular

Every Axis Signal story on this subject — 1 report, filed under Business

Novo Nordisk Shares Drop After Ziltivekimab Fails To Cut Major Heart Events

Business

Novo Nordisk Shares Drop After Ziltivekimab Fails To Cut Major Heart Events

Shareholders reacted as Novo Nordisk’s experimental drug ziltivekimab failed to produce a statistically meaningful reduction in major cardiovascular

Also tagged

Novo Nordisk Ziltivekimab Drug Trials Pharma Stocks